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Abstract
Background: Atherosclerotic cardiovascular diseases (ASCVD) are on the rise in low and middle-income countries
attributed to modern sedentary lifestyle and dietary habits. This has led to the need of assessment of the burden of
at-risk population so that prevention measures can be developed. The objective of this study was to assess ten
years risk assessment of ASCVD using Astro-CHARM and Pooled Cohort Equation (PCE) in a South Asian subpopulation.
Methods: A total of 386 residents of all six districts of Karachi with no ASCVD were enrolled in the study through
an exponential non-discriminative referral snowball sampling technique. The inclusion criteria consisted of age 40
years or above and either gender. Study participants were enrolled after obtaining informed written consent and
those study participants who were found to have either congenital heart disease or valvular heart diseases or
ischemic heart disease were excluded from the study based on initial screening. For the calculation of 10 years risk
of ACVD based on Astro-CHARM and PCE, the variables were obtained including medical history and coronary
artery calcium and C-reactive protein measurements.
Results: Mean estimated 10-year risk of fatal or non-fatal myocardial infarction or stroke as per the Astro-CHARM
was 13.98 ± 8.01%, while mean estimated 10-year risk of fatal or non-fatal myocardial infarction or stroke as per the
PCE was 22.26 ± 14.01%. Based on Astro-CHARM, 11.14% of the study participants were labeled as having high risk,
while PCE estimated 20.73% of study participants as having high risk of ASCVD.
Conclusion: Despite the fact that our findings showed substantial differences in ten-year risk of ASCVD between
Astro-CHARM and PCE, both calculators can be used to develop a new population and specific risk estimators for
this South Asian sub-population. Our study provides the first step towards developing a risk assessment guided
decision-making protocol for primary prevention of ASCVD in this population.
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Background
With the ever-increasing global burden of atherosclerotic
cardiovascular diseases (ACVD) the need to timely assess
the risk of cardiovascular events cannot be more emphasized [1–5]. Once among the most common causes of
death in high-income countries only, ACVD has become
the leading cause of morbidity and mortality in low and
middle-income countries as well owing to epidemiologic
transition and changing population dynamics. This trend
is more prominent in the South Asian population where
(ACVD) is the leading cause of death [6, 7].
A number of risk estimators have been developed to
assess the risk of any cardiovascular event in at-risk
population. Astro-CHARM and Pooled Cohort Equation
(PCE) has been much widely used worldwide however
these estimators have been developed in the west and
not much evidence is present that how accurately they
estimate ACVD in South Asian population [8, 9]. Tariq
et al. [10] reported that the Pakistani population showed
to have a higher risk of ASCVD compared to whites,
blacks, and Hispanic and even South Asians living in
USA. Another study conducted in a similar population
showed that the burden of premature myocardial infarction to be as high as 12% [11]. In addition, another large
multi-centric study from Pakistan attempted to predict
the risk of atherosclerotic cardiovascular disease in Pakistani population, however, included subject with already
suffered from ASCVD [12]. Such methodological flaws
can have serious implications while projecting risk assessment on the general population. There is a scarcity
of literature providing estimates of ASCVD risk in resident South Asian population as well as comparison of
different risk estimators in this population.
Majority of these studies have used PCE as a risk estimator which has its own limitation that includes overestimating the risk in other nationalities/ ethnicities and
in population with less social deformation which requires attention while making medical decisions. To
overcome this Astro-CHARM calculation was used
(Astronaut Cardiovascular Health and Risk Modification). Data in white, Hispanic & black have been elucidated except for the South Asians [8].
Cardiovascular risk can be estimated as either absolute, relative, lifetime, or recurrent. An internationally
agreed-upon guidelines do not exist in this regard [13].
The 10 years risk of coronary events (high, intermediate,
or low) can be determined by various risk scores, such
as laboratory and non-laboratory Framingham risk score
for CVD, systematic coronary risk evaluation, Reynolds
risk score, the Lancet chronic diseases risk charts, World
Health Organization risk charts, etc., but poor concordance has been reported between the risk score, jeopardizing their clinical utility [14]. ACC/AHA preventive
guidelines advocate the use of PCE for the assessment of
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cardiovascular risk [15] and Astro-CHARM is considered to be a significant improvement over the PCE with
the addition of discriminating power of coronary artery calcium (CAC) and hs-CRP [8]. Keeping in mind
the ease of adoption of PCE in a resource-limited setting
and predictive superiority of Astro-CHARM, we assessed
the risk of ASCVD in our population using both
modalities.
This study, to the best of our knowledge, attempted to
estimate the ten-year risk of ASCVD in general population without any history of ASCVD using both AstroCHARM and PCE, the aim of this study was to estimate
risk and compared both the modalities.

Methods
This analytical cross-sectional study was conducted
among 386 residents of all six districts of Karachi
who had no prior history of atherosclerotic cardiovascular disease including stroke. Study was approved by
the ethical review committee of the National Institute
of Cardiovascular Diseases (NICVD) Karachi, Pakistan
(ERC-29/2018). Karachi is the largest metropolitan
city of the country with a diverse ethnic distribution,
inhabiting around 15 million people with a fair share
of all the ethnicities residing in the country. Due to
non-availability of the sampling frame for any probability sampling technique, non-probability snowball
sampling technique was adopted. Starting with the recruitment of consenting individuals, for all six districts of the city, meeting the inclusion criteria of the
study from healthy attendants visiting our center. The
exponential non-discriminative referral technique was
adopter where every recruited participant was allowed
multiple referrals from his/her acquaintances. All the
referrals were contacted and directed to a designated
desk at the doctor’s office for initial screening and assessment. After a thorough history, physical, and electrocardiographic assessment to rule out underlying
atherosclerotic cardiovascular disease, participants of
both gender and age between 40 to 65 years were included in this study. Study participants were enrolled
after obtaining informed written consent and those
study participants who were found to have either
congenital heart disease or valvular heart diseases or
ischemic heart disease were excluded from the study
based on initial screening. Individuals who refused or
shown reluctance to accept computed tomography
angiography (CTA) or other laboratory assessments
such as lipid profile or C-reactive protein (hs-CRP)
were excluded after an initial assessment.
Fasting (12 h) lipid profile and hs-CRP level were obtained for all the enrolled patients and for the calculation
of 10 years risk of ACVD based on Astro-CHARM and
PCE, the variables were obtained in the following manner.
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Diabetes mellitus, hypertension, current smoking, and
family history of heart attack were defined as per AstroCHARM definitions [8].
High-sensitivity C-reactive protein (hs-CRP) levels were
measured by using the following assays. MESA, BNII
nephelometer (N High Sensitivity CRP; Dade Behring
Inc); DHS, Roche/Hitachi 912 System, Tina-quant assay
(Roche Diagnostics), alatex-enhanced immunoturbidimetric method; PACC, particleenhancedimmune turbidimetric latex agglutination assay; FHS, enhanced immune
turbidimetric high-sensitivity assay (Roche Diagnostics).
Computed tomography angiography (CTA) was performed in all the patients and coronary artery calcium
(CAC) score was calculated for all the patients.
Data were entered using MS Excel for Windows and analyses were done using STATA 11.0 while 10 years risk of
ACVD was calculated using Astro-CHARM and PCE using
the online calculators available at www.AstroCHARM.org
and www.clincalc.com respectively. Participants were stratified as low-risk and high-risk individuals based on cut-off
have of ≥7.5% for both Astro-CHARM and PCE.
Descriptive analyses were conducted by calculating the
mean and standard deviation for all continuous variables
while frequency and percentages were calculated for all
categorical variables. Comparison between male and female participants on continuous variables was made by
performing independent sample t-test and categorical

variables were compared by applying Chi-square test
and p-value ≤0.05 as taken as criteria for statistical significance. Risk of ACVD was reported using both equations for the combined study population and was also
stratified for different sub-groups.

Results
Mean age of the study participants was 49 ± 7.10 years
with 54% Males. Mean BMI was 28.11 ± 5.38 while 45.6,
15.8, and 14.2% were hypertensive, diabetics and current
smokers respectively. Six (2 %) of the study participants
had all three co-morbid conditions. Thirty percent had
positive family history of MI. Mean CAC was 7.50 ±
14.05 Agatston units. Table 1 shows the baseline sociodemographic and medical characteristics of study participants stratified by gender.
Mean estimated 10-year risk of fatal or non-fatal myocardial infarction or stroke as per the Astro-CHARM
was 13.98 ± 8.01%, while mean estimated 10-year risk of
fatal or non-fatal myocardial infarction or stroke as per
the PCE was 22.26 ± 14.01%. Risk comparison in different age categories showed a significantly higher risk of
ACVD in age groups of 55–60 years and 60 years and
above compared to the ASCVD risk in the age group
40–45 years as shown in Fig. 1.
Similarly, Table 2 below shows the comparison of
baseline characteristics of high and low-risk individuals

Table 1 Baseline socio-demographic and medical characteristics of study participants
Baseline characteristics

Overall
N = 386

P-value

Gender
Male
N = 211

Female
N= 175

Age (years)a

49 ± 7.11

49.47 ± 7.24

48.43 ± 6.93

0.153

Body mass index (kg/m2)a

28.12 ± 5.39

26.93 ± 4.71

29.55 ± 5.8

< 0.001

Coronary artery calcium (Agatston units)a

31.57 ± 195.63

44.61 ± 253.95

15.86 ± 79.94

0.121

Total cholesterol (mg/dL)a

177.65 ± 38.97

174.91 ± 37.02

180.94 ± 41.07

0.131

HDL cholesterol (mg/dL)

51.73 ± 36.78

50.93 ± 48.39

52.7 ± 12.85

0.639

Systolic blood pressure (mmHg)a

138.83 ± 21.23

135.73 ± 20.81

142.57 ± 21.18

0.002

Yes

176 (45.6%)

78 (36.97%)

98 (56%)

< 0.001

No

210 (54.4%)

133 (63.03%)

77 (44%)

Yes

61 (15.8%)

34 (16.11%)

27 (15.43%)

No

325 (84.2%)

177 (83.89%)

148 (84.57%)

Yes

55 (14.25%)

50 (23.7%)

5 (2.86%)

No

331 (85.75%)

161 (76.3%)

170 (97.14%)

Yes

118 (30.57%)

66 (31.28%)

52 (29.71%)

No

268 (69.43%)

145 (68.72%)

123 (70.29%)

a

Hypertensive

Diabetic
0.854

Current Smoker
< 0.001

Family History of Myocardial Infarction

a

reported as mean and standard deviation, all other variables are reported as frequencies and percentages

0.74
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Fig. 1 The comparison of mean 10-years risk of ASCVD for different age groups as calcualted by Astro-CHARM and PCE

based on Astro-CHARM and Pooled Cohort Estimator.
Kappa agreement between the two calculators in terms
of labeling high and low-risk individuals was high (0.50,
p-value < 0.0001).
Out of 386 individuals, 8.8% (34) were categorized as
high risk by both Astro-CHARM and PCE and 76.9%
(297) were categorized as low risk by both AstroCHARM and PCE. Taking Astro-CHARM as gold standard for categorizing high risk individuals, PCE has sensitivity of 79.07%, specificity of 86.59%, positive predictive
value of 42.50%, and negative predictive value of 97.06%,
as presented in Table 3.

Discussion
To the best of our knowledge, current study reports 10
year risk of ASCVD among non-cardiac Pakistani population using both Astro-CHARM and PCE and the
comparison of the two calculators for the first time. In
concordance with the findings of other studies, PCE
estimated the risk of ASCVD in the study population
almost twice as that estimated by Astro-CHARM. AstroCHARM which also includes indicators like coronary
artery calcium and C-reactive protein during ASCVD
risk assessment, these indicators are not readily available
in low and middle-income countries, therefore, the
significance of PCE cannot be neglected [16].
One of the key findings of this study was that both
coronary artery calcium and C reactive protein significantly correlated with the risk scores generated by PCE
which is in concordance with findings from other studies

[17, 18]. Especially in the case of CAC, a relatively recent
study by JJ Carr et al. [17] reported its effect on the risk
of ASCVD among individuals well below 40 years of age.
Keeping in mind that said study was conducted among
African-Americans and Caucasians, who are relatively at
lower risk of developing ASCVD compare to South
Asians, it points towards a major limitation of these risk
calculators among South Asians, who, in clinical experience suffer cardiac events at an even younger age [19]
and evidenced by the previous study from Pakistan [10],
there is a dire need of development of populationspecific risk estimator for the South Asian population.
This study provided the grounds towards developing
such risk estimator as well as initial step towards developing evidence-based decision making for primary prevention guidelines of atherosclerotic cardiovascular
disease in this population.
Considering the fact that the population of South
Asian countries consists of multi-ethnical groups with
possibly different inherent risk of developing ASVD, as
well as the absence of risk estimators in population
below 40 years of age much evidence is required to develop population-specific risk estimators and risk guided
decision-making tools for primary prevention among
South Asians using robust study designs. Furthermore,
considering the sub-optimal healthcare systems and the
absence of expensive investigating facilities like CAC in
low and middle-income countries of South Asia, the
development of risk estimators for these populations
also requires large population-based, ethnicity and
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Table 2 Comparison of baseline characteristics of high and low risk individuals based on Astro-CHARM and Pooled Cohort Estimator
Characteristics

Astro-CHARM

PCE

Low Risk
N = 343

High Risk
N = 43

Low Risk
N = 306

High Risk
N = 80

Male

51.9% (178)

76.7% (33)

47.4% (145)

82.5% (66)

Female

48.1% (165)

23.3% (10)

52.6% (161)

17.5% (14)

Weight (kg)

73 ± 15

74 ± 14

74 ± 15

72 ± 13

Height (cm)

162 ± 11

165 ± 10

161 ± 11

166 ± 10

Age (years)

48 ± 7

55 ± 7

47 ± 6

57 ± 6

Yes

44.6% (153)

53.5% (23)

44.4% (136)

50% (40)

No

55.4% (190)

46.5% (20)

55.6% (170)

50% (40)

Yes

11.1% (38)

53.5% (23)

8.8% (27)

42.5% (34)

No

88.9% (305)

46.5% (20)

91.2% (279)

57.5% (46)

Yes

11.1% (38)

39.5% (17)

9.2% (28)

33.8% (27)

No

88.9% (305)

60.5% (26)

90.8% (278)

66.2% (53)

28.6% (98)

46.5% (20)

32% (98)

25% (20)

Gender

Hypertensive

Diabetic

Current Smoker

Family History of Myocardial infarction
Yes
No
Coronary Artery Calcium (Agatston)

71.4% (245)

53.5% (23)

68% (208)

75% (60)

9.9 ± 46.42

204.2 ± 546.76

15.5 ± 73.87

93 ± 400.79

Total Cholesterol (mg/dL)

178 ± 37

178 ± 50

175 ± 39

187 ± 37

HDL Cholesterol (mg/dL)

53 ± 39

45 ± 10

53 ± 41

45 ± 11

Systolic Blood Pressure (mmHg)

137 ± 20

155 ± 21

137 ± 20

148 ± 22

Astro-CHARM Astronaut Cardiovascular Health and Risk Modification; PCE Pooled Cohort Equation
Low-Risk = < 7.5% estimated 10 years risk; High-Risk = ≥7.5% estimated 10 years risk

age-specific data to develop such a tool using both
Astro-CHARM and PCE. Low and middle-income
countries are now overburdened with interventional
procedures like angioplasty, and expensive methods of
secondary prevention. Accurate risk assessment is the
only solution in such resource-poor settings where
Table 3 Cross tabulation of Pooled Cohort Estimator against
Astro-CHARM for categorizing high risk individuals
Astro-CHARM
Low Risk

High Risk

PCE
Low Risk
High Risk

76.9% (297)

2.3% (9)

11.9% (46)

8.8% (34)

Sensitivity

79.07% (95% CI: 63.96 to 89.96%)

Specificity

86.59% (95% CI: 82.52 to 90.01%)

Positive predictive value

42.50% (95% CI: 35.16 to 50.19%)

Negative predictive value

97.06% (95% CI: 94.85 to 98.34%)

Astro-CHARM Astronaut Cardiovascular Health and Risk Modification, PCE
Pooled Cohort Equation, CI Confidence interval
Low-Risk = < 7.5% estimated 10 years risk; High-Risk = ≥7.5% estimated
10 years risk

primary prevention can be implicated through lifestyle
modifications and statins among high-risk individuals.
However, overestimation and misclassification of an
individual as high risk has its own implications too,
not only at the individual level but also at healthcare
system level, therefore, accuracy of the risk stratification modality is crucial.

Strengths and limitations

The biggest strength of the study is the use and comparison of both ASCVD estimators in non-cardiac Pakistani general population selected from the largest city of
the country with diverse population sub-groups from the
entire country thus providing data facsimile to general
population of Pakistan.
Major limitations of the study lie in the nonprobability snowball sampling technique and study design where lack of prospective follow-up cannot ensure
the accuracy of these estimates. Furthermore, the data
was taken from an urban setting and implications of the
findings cannot be ascertained on the rural population.
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Conclusion
Despite the fact that our findings showed substantial differences in 10-year risk of ASCVD between AstroCHARM and PCE, both calculators can be used to develop a new population and specific risk estimators for
this South Asian sub-population. Our study provides the
first step towards developing a risk assessment guided
decision-making protocol for primary prevention of
ASCVD in this population.
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